These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30916611)

  • 21. The influence of the CYP2C19*10 allele on clopidogrel activation and CYP2C19*2 genotyping.
    Langaee TY; Zhu HJ; Wang X; El Rouby N; Markowitz JS; Goldstein JA; Johnson JA
    Pharmacogenet Genomics; 2014 Aug; 24(8):381-6. PubMed ID: 24945780
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cytochrome P450 2C19 polymorphism on adverse cardiovascular events after drug-eluting stent implantation in a large Hakka population with acute coronary syndrome receiving clopidogrel in southern China.
    Zhong Z; Hou J; Zhang Q; Li B; Li C; Liu Z; Yang M; Zhong W; He X; Wu H; Zhong M; Zhao P
    Eur J Clin Pharmacol; 2018 Apr; 74(4):423-431. PubMed ID: 29243114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Association of CYP2C19 gene polymorphisms with long-term recurrent risk of ischemic stroke among ethnic Han Chinese from Fujian].
    Fang L; Zhao Y; Wang N; Yang Z; Huang H; Lin M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):871-6. PubMed ID: 26663068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of CYP2C19*4B: pharmacogenetic implications for drug metabolism including clopidogrel responsiveness.
    Scott SA; Martis S; Peter I; Kasai Y; Kornreich R; Desnick RJ
    Pharmacogenomics J; 2012 Aug; 12(4):297-305. PubMed ID: 21358751
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of pharmacogenomic variants affecting the efficacy of clopidogrel therapy in the Hispanic Community Health Study/Study of Latinos cohort.
    Melin K; Moon JY; Qi Q; Hernandez-Suarez DF; Duconge J; Hua S; Gonzalez S; Zeng D; Kaplan RC
    Pharmacogenomics; 2019 Jan; 20(2):75-83. PubMed ID: 30520344
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Influence of CYP2C19 loss-of-function variants on the antiplatelet effects and cardiovascular events in clopidogrel-treated Chinese patients undergoing percutaneous coronary intervention.
    Zou JJ; Xie HG; Chen SL; Tan J; Lin L; Zhao YY; Xu HM; Lin S; Zhang J; Wang GJ
    Eur J Clin Pharmacol; 2013 Apr; 69(4):771-7. PubMed ID: 23001453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of ABCB1, CYP3A5, CYP2C19, and P2RY12 gene polymorphisms in a Mexican Mestizos population.
    Vargas-Alarcón G; Ramírez-Bello J; de la Peña A; Calderón-Cruz B; Peña-Duque MA; Martínez-Ríos MA; Ramírez-Fuentes S; Pérez-Méndez O; Fragoso JM
    Mol Biol Rep; 2014 Oct; 41(10):7023-9. PubMed ID: 25106522
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CYP2C19-rs4986893 confers risk to major depressive disorder and bipolar disorder in the Han Chinese population whereas ABCB1-rs1045642 acts as a protective factor.
    Zhang T; Rao Q; Lin K; He Y; Cai J; Yang M; Xu Y; Hou L; Lin Y; Liu H
    BMC Psychiatry; 2023 Jan; 23(1):69. PubMed ID: 36698099
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction analysis between genetic polymorphisms and pharmacodynamic effect in patients treated with adjunctive cilostazol to dual antiplatelet therapy: results of the ACCEL-TRIPLE (Accelerated Platelet Inhibition by Triple Antiplatelet Therapy According to Gene Polymorphism) study.
    Kim IS; Jeong YH; Park Y; Yoon SE; Kwon TJ; Park JR; Hwang SJ; Koh EH; Kwak CH; Hwang JY; Kim S
    Br J Clin Pharmacol; 2012 Apr; 73(4):629-40. PubMed ID: 22007612
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of Genetic Polymorphisms on Clopidogrel Response and Clinical Outcomes in Patients with Acute Ischemic Stroke CYP2C19 Genotype on Clopidogrel Response.
    Han Y; Lv HH; Liu X; Dong Q; Yang XL; Li SX; Wu S; Jiang JM; Luo Z; Zhu DS; Zhang Y; Zheng Y; Guan YT; Xu JF
    CNS Neurosci Ther; 2015 Sep; 21(9):692-7. PubMed ID: 26177117
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of polymorphisms in the CYP2C19 and ABCB1 genes among patients with acute coronary syndrome in Lower Silesian population.
    Wójcik T; Szymkiewicz P; Wiśniewski J; Lebioda A; Jonkisz A; Gamian A; Kuliczkowski W; Ściborski K; Mysiak A; Protasiewicz M
    Adv Clin Exp Med; 2019 Dec; 28(12):1621-1626. PubMed ID: 31778598
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of CYP2C19, P2Y12, and ABCB1 polymorphisms and phenotypic response to clopidogrel in healthy Indian adults.
    Sridharan K; Kataria R; Tolani D; Bendkhale S; Gogtay NJ; Thatte UM
    Indian J Pharmacol; 2016; 48(4):350-354. PubMed ID: 27756942
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pilot study for the characterization of pharmacogenetically relevant CYP2D6, CYP2C19 and ABCB1 gene polymorphisms in the Hungarian population.
    Rideg O; Háber A; Botz L; Szücs F; Várnai R; Miseta A; Kovács GL
    Cell Biochem Funct; 2011 Oct; 29(7):562-8. PubMed ID: 21826689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples.
    Davis BH; DeFrank G; Limdi NA; Harada S
    Clin Transl Sci; 2020 Mar; 13(2):260-264. PubMed ID: 31664775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the incremental prognostic value of the combination of CYP2C19 poor metabolizer status and ABCB1 3435 TT polymorphism over conventional risk factors for cardiovascular events after drug-eluting stent implantation in East Asians.
    Park MW; Her SH; Kim CJ; SunCho J; Park GM; Kim TS; Choi YS; Park CS; Koh YS; Park HJ; Kim PJ; Chung WS; Seung KB; Kim HS; Shin JG; Chang K
    Genet Med; 2016 Aug; 18(8):833-41. PubMed ID: 26699760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of 50 SNPs in CYP2D6, CYP2C19, CYP2C9, CYP3A4 and CYP1A2 by MALDI-TOF mass spectrometry in Chinese Han population.
    Shi Y; Xiang P; Li L; Shen M
    Forensic Sci Int; 2011 Apr; 207(1-3):183-7. PubMed ID: 21071160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Validation and Application of a Novel CYP2C19 Genotyping Approach Based on Capillary Electrophoresis in Chinese Han population.
    Chen D; Wu Y; Wang Y; Yu H; Lai L; Huang Y
    Clin Lab; 2022 Nov; 68(11):. PubMed ID: 36378005
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effects of CES1A2 A(-816)C and CYP2C19 loss-of-function polymorphisms on clopidogrel response variability among Chinese patients with coronary heart disease.
    Xie C; Ding X; Gao J; Wang H; Hang Y; Zhang H; Zhang J; Jiang B; Miao L
    Pharmacogenet Genomics; 2014 Apr; 24(4):204-10. PubMed ID: 24535487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of CYP2C19 genetic polymorphisms in a Korean population using a simultaneous multiplex pyrosequencing method to simultaneously detect the CYP2C19*2, CYP2C19*3, and CYP2C19*17 alleles.
    Kim KA; Song WK; Kim KR; Park JY
    J Clin Pharm Ther; 2010 Dec; 35(6):697-703. PubMed ID: 21054462
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2C19 polymorphism and antiplatelet effects of clopidogrel in Chinese stroke patients.
    Yang J; Zhao HD; Tan J; Ding YL; Gu ZQ; Zou JJ
    Pharmazie; 2013 Mar; 68(3):183-6. PubMed ID: 23556336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.